Drugs / molecular iodine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00237523 | Jul 2005 → Mar 2008 | breast fibrocystic disease | Symbollon Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | molecular iodine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00237523 ↗ |
| Known as | IoGen | “IoGen (molecular iodine)” NCT00237523 ↗ |